BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹362 Cr | ₹29,571,376 Cr | ₹0.00 Cr | ₹184 Cr | ₹116 Cr |
What is the latest Revenue of BETA DRUGS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹362 Cr |
| Mar2025 | ₹29,571,376 Cr |
| Mar2024 | ₹0.00 Cr |
| Mar2023 | ₹184 Cr |
| Mar2022 | ₹116 Cr |
How is Revenue of BETA DRUGS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹362 Cr | -100.00 | |
| Mar2025 | ₹29,571,376 Cr | 1,478,568,796,850.00 | |
| Mar2024 | ₹0.00 Cr | -100.00 | |
| Mar2023 | ₹184 Cr | 58.31 | |
| Mar2022 | ₹116 Cr | - | |
Compare Revenue of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹1,837.5 Cr | -8.9% | -16% | 6.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -8.9% |
-16% |
6.7% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses